Skip to content

Lose weight

Weight loss medications provide drug support for individuals who are having difficulty losing weight by interfering with various body processes, such as appetite control or fat burning. It is important to consider their use as part of a comprehensive weight management plan that includes dietary changes and physical activity to achieve lasting results.


This collection is empty

View all products

Importance of obesity fighting

Obesity, or obesity, is a serious health problem that continues to increase worldwide. The importance of combating obesity lies not only in the aesthetic component, but above all in the health risks associated with overweight. Obosity can lead to a variety of diseases such as type 2 diabetes, heart disease, stroke, certain types of cancer and other serious health problems.

Combating obesity requires a holistic approach that includes nutrition, physical activity and lifestyle changes. It is important to educate the public about the risks of overweight and to promote access to healthy food and movement options.

In addition, governments and health organizations have to take measures to design the surroundings in such a way that it supports a healthy lifestyle, for example by creating safe cycle paths, promoting sports in schools and the regulation of advertising for unhealthy food. The importance of obesity control is therefore to protect the health of the population and to protect the health system from excessive stress.

Overview of medication for weight loss

Various drugs are available to support weight reduction, which can be used as required and severe degrees of obesity. The over -the -counter drugs include, for example, appetite suppressants that promote saturation in the brain and thus reduce the feeling of hunger. These drugs mostly contain active ingredients such as L-Carnitine or Glucomannan and can be taken in the form of tablets or powder.

For more serious cases of obesity, prescription drugs are also available, such as orlistat or liraglutid that inhibit the fat intake in the body or increase the feeling of satiety. These drugs are mostly used in combination with a calorie -reduced diet and increased physical activity.

It is important to note that all drugs for weight reduction can have potential side effects, such as gastrointestinal complaints, headaches or sleep disorders. Before taking medication, a doctor should therefore always be consulted to determine the best treatment method.

Understand obesity

Obesity, also known as obesity, is a serious health problem that increases worldwide. It is often considered a complex interplay of genetic, behavioral and environmental factors. Obosity can lead to a variety of health problems such as diabetes, cardiovascular diseases, stroke and even cancer. It is important to understand the causes and consequences of obesity in order to develop effective prevention and treatment strategies. In this context, it is crucial to understand the risk factors, the role of nutrition and movement, genetic predispositions and the influence of the environment on the development of obesity. It is also important to take into account the social, psychological and economic effects of obesity. It is therefore of the utmost importance that we deal comprehensively with the topic of obesity in order to improve the health and well -being of our population.

Definition of obesity

Obesity is defined as a condition of the excessive body fat, which is an increased health risk. It can be classified based on the body mass index (BMI), whereby various degrees of obesity can be determined. A BMI of 30 to 34.9 is considered an obesity grade I, 35 to 39.9 as an obesity grade II and from a BMI of 40 as obesity grade III. Obesity can lead to various health problems, including cardiovascular diseases, type 2 diabetes, certain types of cancer and other serious illnesses. It is important to recognize and treat obesity at an early stage in order to minimize health risks and improve the quality of life.

Types of obesity (heavy, pathological)

There are different types of obesity, including severe and pathological obesity. Heavily overweight people have a BMI of 30 or higher, while pathologically overweight people have a BMI of 40 or higher. The health effects of severe and pathological obesity can be serious and diseases such as type 2 diabetes, heart disease, high blood pressure and joint problems.

The different categories of obesity are obesity grade 1 (BMI 30-34.9), obesity grade 2 (BMI 35-39.9) and obesity grade 3 (BMI 40 or higher). An example of severe obesity is a person with a BMI of 35, while an example of pathological obesity is a person with a BMI of 40 or higher.

It is important to note that both serious and pathological obesity can cause serious health problems and that timely treatment is required to minimize the complications. It is important to maintain a healthy lifestyle and promote regular movement in order to reduce the risk of obesity.

Health risks related to obesity

Obesity is associated with numerous health risks, including cardiovascular diseases, type 2 diabetes, high blood pressure, stroke, certain types of cancer, breathing problems and joint problems. People with obesity have an increased risk of suffering from these diseases, which can significantly affect their quality of life. In order to counteract these risks, it is important to take measures to take away weight, such as a healthy diet and regular physical activity. In some cases, medication for the treatment of obesity can be considered to help patients lose weight and reduce health problems.

The health effects of obesity on the body can be varied, including increased stress on the heart, joints and metabolism. Preventive measures include healthy eating, regular exercise and avoiding excessive consumption of high -fat and sugar -containing foods. It is important that people with obesity regularly use medical care to recognize and treat potential health problems before they have serious consequences.

Treatment options for obesity

Obesity and obesity are serious health problems that affect many people around the world. Fortunately, there are various treatment options that can support people in reducing their weight and improving their health. From changes in lifestyle to drug treatments to surgical interventions, there are a variety of options to help people with obesity to lose weight and live healthier.

Changes to the lifestyle

Changes to lifestyle play a crucial role in weight management. This includes, for example, switching to healthier options, reducing alcohol consumption, increasing physical activity and improving the sleep pattern. These changes not only support the achievement of healthy weight, but also contribute to general health and well -being.

In some cases, weight loss medication can also play a role in supporting weight management, but should always be taken in consultation with a doctor.

In the long term, successful habit changes require patience, discipline and support. This includes regular exercise, balanced nutrition, stress management and emotional well -being. A continuous connection with qualified experts, such as nutritionists or therapists, is also important to learn and maintain long -term healthy habits.

Medicines with strong overweight and obesity

If you suffer from strong overweight or obesity, taking medication can be an option to help you with weight. Medicines can be prescribed in connection with a healthy diet and regular exercise to support the process. However, it is important to understand the risks and side effects and to discuss with a doctor before you start taking it. Here are some important information that you should take into account.


Polyglucosamine is a dietary supplement that can help with the health of the joints and osteoarthritis symptoms. Its function is to maintain the integrity of the articular cartilage and reduce inflammation.

It is recommended to follow the instructions on the packaging or instructions from a doctor when taking polyglucosamine in order to ensure safe application and minimize possible side effects. As a rule, it is recommended to take it with meals to improve the recording and to minimize the risk of stomach complaints.

The dosage of polyglucosamine depends on factors such as age, weight and severity of the joint problems. To determine the correct dosage, it is important to consult a doctor. It is important to be careful because there can be interactions with medication such as blood thinners and possible effects on vitamin intake.

Possible risks and complications in taking polyglucosamine can be an increased blood sugar level in allergic reactions, gastrointestinal complaints and, in rare cases,. When the effects occur, it is recommended to cancel the intake and see a doctor. Polyglucosamine can provide relief for joint complaints with intended use and under medical supervision.


Glucomannan is a natural fiber that is used in many weight loss pills to increase the feeling of satiety and promote weight loss. Studies have shown that Glucomannan can reduce fat intake in the body and regulate insulin levels. However, there are also potential risks when taking glucomannan, especially if there is not enough water. Since Glucomannan is extremely water -absorbing, constipation or even a intestinal lock can occur if the fluid is insufficient. For this reason, the manufacturers of Glucomannan preparations expressly warn against accompanying the intake with sufficient water in order to avoid the risk of suffocation. So it is particularly important to adhere to the recommended dosage and drink enough water to minimize the potential risks. Ultimately, it is always advisable to consult a doctor before taking Glucomannan acceptance pills to ensure that they are suitable for individual health.


Sympathomimetics, also known as appetite suppressants, have often been used to treat overweight and obesity in the past. These active ingredients affect the central nervous system and lead to reduced food intake and increased energy consumption.

However, experts today advise largely from the use of sympathomimetics as appetizers because the potential risks and side effects can be serious. These include cardiac arrhythmias, high blood pressure, sleep disorders, nervousness and dependency potential.

The approved short-term therapy for the use of sympathomimetics for weight reduction is usually a maximum of 12 weeks. Longer use times can lead to serious health problems.

It is important that people who consider weight loss tablets with sympathomimetics, are aware of the potential dangers and risks and advise themselves with a doctor before use. The use of sympathomimetics for weight reduction should only be considered as the last option after other measures for weight loss have been unsuccessful.

How effective are food supplements for losing weight?

Dietary supplements for losing weight can work in different ways. Some can reduce appetite, increase fat burning or influence the absorption of nutrients. They often contain ingredients such as green tea extract, caffeine, fiber substances or Garcinia Cambogia, which can supposedly support weight loss.

However, it is important to note that dietary supplements are not without risks. Possible side effects can be gastrointestinal complaints, rapid heartbeat, insomnia, headache or dizziness. Some ingredients can also cause allergic reactions. In addition, dietary supplements should not be seen as a replacement for a balanced diet and regular exercise.

It is advisable to consult a doctor before taking nutritional supplements to lose weight, especially if there are already existing health problems. It is important that consumers are informed about the potential risks and are aware that dietary supplements do not always provide the promised results, but can even cause health problems.

Which drugs help with obesity?

Obesity, also known as obesity, is a serious illness that can lead to a variety of health problems. People who suffer from obesity often have difficulty losing weight, even with diet and movement. In some cases, the use of medication together with a healthy lifestyle can help reduce weight and reduce the risk of complications. There are various drugs that can help with the treatment of obesity, including appetite suppressants, medicines that reduce fat recording in the body, and medication that stimulates metabolism.

Here are some of the most frequently prescribed medication for the treatment of obesity:

- phenter

- Orlistat

- liraglutid

- Naltrexon/bupropion

- Phenter date/topiramate

However, before one of these drugs is considered, it is important to speak to a doctor or pharmacist in order to understand the risks and advantages and find out whether they are suitable for the individual situation. It is also important to note that medication alone is not enough to lose weight and that they should be used in combination with a healthy diet and regular exercise.

Without a prescription: Which tablets help you lose weight?

Medicines for weight loss, such as the weight loss injection and GLP-1 receptor agonists, have potential security concerns and side effects that must be carefully taken into account. The European Medicines Authority EMA is currently examining the security of medication such as Wegovy, Ozempic and Saxenda due to possible serious side effects, including suicidal thoughts and self -harm. Another worrying side effect is the increased risk of thyroid cancer when taking Semaglutid preparations.

It is important that potential side effects of these drugs are taken seriously because they can have serious effects. People who take these medication should be aware of the possible risks and carry out regular medical controls in order to recognize any side effects at an early stage.

These security concerns underline the importance of a comprehensive approach for weight management, which also includes nutrition, movement and behavioral therapy. Before you decide to take medication for weight loss, it is crucial to speak to a doctor and carefully weigh up all potential risks.

Prescription drugs for obesity

In Germany, some prescription drugs for the treatment of obesity are approved. This includes orlistat, liraglutid, semaglutid and the active ingredient combination naltrexon/bupropion.

Orlistat works by reducing the absorption of fat from food in the intestine, while Liraglutid and Semaglutid act on the brain and increase the feeling of satiety. The active ingredient combination Naltrexon/Bupropion influences the reward centers in the brain and thus reduces the desire for food.

These drugs are usually used in combination with low -calorie diet and movement therapy. The prerequisites for a prescription vary depending on the medication, but can be, for example, a BMI over 30 or over 27 in combination with other diseases such as diabetes.

Obesity medication should only be used under medical supervision and are not suitable for all patients. Side effects and contraindications should always be observed. The choice of suitable drug depends on individual factors and risks.

Disadvantages of medication for losing weight

Medicines for losing weight are often advertised as a quick solution for weight loss. But as with any kind of medication, there are also disadvantages to consider here. Taking such medication can lead to undesirable side effects and cause long -term health problems. It is important to be clear about the potential risks before you decide to take weight loss medication.

Movement therapy

Movement therapy plays a crucial role in increasing metabolism and improving health. Metabolic processes can be optimized through regular physical activity, such as endurance and strength training, which in turn contributes to better calorie burning and a healthy weight. Recommended activities for effective movement therapy include jogging, swimming, cycling and aerobics exercises.

In addition, it is important to integrate movement into everyday life, such as by climbing stairs and active breaks at work. Movement therapy increases the energy turnover of the body, which not only contributes to weight loss, but also reduces the risk of metabolic disorders such as diabetes and cardiovascular diseases.

Regular movement also stimulates the production of endorphins, which leads to a better mood and an increased quality of life. Overall, movement therapy is an important measure to improve metabolism and promote health.

Behavioral therapy

Behavioral therapy for weight loss aims to replace unhealthy behaviors in terms of nutrition and exercise with healthier. This is achieved by teaching the patients new strategies and habits in dealing with food and movement. In addition, it is being worked on to recognize and manage conflicts that can lead to overdrafts. In addition, thought patterns and settings that contribute to unhealthy eating behavior are addressed and changed.

Behavioral therapy can take place both as individual and group therapy. In individual therapy, the therapist has the opportunity to deal intensively with the individual patient and to develop very personal strategies. In group therapy, on the other hand, participants can learn from each other, motivate and support each other. In addition, the group offers a social environment in which patients learn to practice their new behavior in real everyday situations. The choice between individual and group therapy depends on the individual needs and preferences of the patient.

Dietary change

The change in diet plays a crucial role in the treatment of obesity and long -term weight loss. In contrast to short-term diets, which are often not sustainable and cause the dreaded yo-yo effect, the change in diet relies on long-term changes in eating habits and lifestyle. This can help to reduce the risk of cardiovascular diseases, diabetes and other health problems associated with obesity.

In certain cases, weight loss medication can be prescribed as a supplement to the change in diet.

Various factors are crucial for a sustainable change in diet and the development of healthy habits, including the integration of movement into everyday life, a balanced diet, regular meals, support from experts and the adaptation of your own eating behavior.

Keywords: change in nutrition, obesity, weight loss medication, weight loss


Surgical interventions for the treatment of obesity include various processes that aim to reduce the weight of a patient and to minimize the associated health risks. The most frequently used methods are the gastric bypass and the tube stomach surgery. In the stomach bypass, a small part of the stomach is separated and connected directly to the small intestine, which means that the food path is shortened and the body can absorb fewer nutrients. In the case of the tube stomach surgery, the stomach is reduced by removing a large part, which leads to a faster feeling of satiety and reduced food intake.

Studies have shown that these surgical interventions are effective in weight loss and can help reduce weight problems and associated health risks such as diabetes and high blood pressure. The prerequisites for the implementation of such interventions can be a body mass index (BMI) of over 40 or a BMI of over 35 in combination with a serious illness caused by overweight. In addition, patients must be clear about the risks and potential side effects of these operations.

Losing weight with syringe: Who is the drug Wegovy thought for?

Prescription drugs for the treatment of obesity in Germany include Orlistat (Xenical), Liraglutid and Semaglutid. These drugs are prescribed for people with a body mass index (BMI) of 30 or higher, or for people with a BMI of 27 or higher who also suffer from side diseases such as type 2 diabetes. Orlistat works by reducing the absorption of fat in the intestine, while Liraglutid and Semaglutide increase the feeling of satiety and reduce the appetite.

Side effects of orlistat can be gastrointestinal complaints and greasy stool, while liraglutid and semaglutid can cause nausea, vomiting and diarrhea. Caution should be exercised in the combination of active ingredients because it can increase the risk of cardiovascular diseases.

The new drug Wegovy (Semaglutid) is approved for adults with a BMI of 30 or higher or a BMI of 27 or higher in connection with at least one weight-related commentary. It can only be applied to medical prescription and has similar side effects to the other drugs for the treatment of obesity.

It is important to note that over -the -counter preparations for weight loss are to be enjoyed with caution, as they can have potentially dangerous side effects. Always consult with a doctor before deciding on drug treatment of obesity.

WEGOVY: Trend in Hollywood

Wegovy, a new drug to combat obesity, triggered a real trend in Hollywood. Celebrities like Elon Musk and Kim Kardashian have publicly announced that they use Wegovy to reduce weight. This has contributed to the fact that the medication has become increasingly popular in the High Society Hollywoods.

Wegovy, which was developed by the pharmaceutical company Novo Nordisk, is a form of Semaglutide, a hormone that reduces appetite and promotes the feeling of satiety. Studies have shown that it can lead to significant weight loss if used regularly. This has made it an attractive option for people with obesity, especially for those who had difficulties with conventional diets and motion programs.

The public announcement of celebrities to use Wegovy has led to the drug has gained popularity both in Hollywood and in the general public. This has contributed to increasing awareness of obesity and the various treatment options and could help improve the combating of obesity as a whole.

EU approval since January 2022

Semaglutid is a medication used to take weight and regulate the appetite. It has been approved in the EU since January 2022. The drug works by increasing insulin secretion, reducing blood sugar levels and increasing the feeling of satiety. Studies have shown that Semaglutid can help reduce body weight with overweight or obese people.

Semaglutid is currently not available in Germany, since the approval and availability of medication in every country is regulated by the respective health authorities. It is expected that Semaglutid will be available in Germany in the near future as soon as the necessary approval procedures have been completed.

The main effects of SEMAGLUTID on the body include weight reduction, improvement in blood sugar levels and increasing the feeling of satiety. The drug is intended for people with type 2 diabetes and obesity or obesity who have difficulty controlling their weight. It can also be considered for people without diabetes who need support for weight loss. Semaglutid has the potential to help people with weight and improve their health.

Who is the medication intended for?

The drug Wegovy is for overweight adults with a body mass index (BMI) of 30 or higher or for adults with a BMI of 27 or higher that suffer from at least one weight-related illness, such as type 2 diabetes or high blood pressure, thought.

The specific criteria for the use of Wegovy include that the drug should be taken together with a calorie -reduced diet and increased physical activity. It is recommended to prescribe Wegovy only for patients who do not respond to conservative weight loss therapy.

As an alternative to Wegovy, there are other prescription drugs for weight loss, but it is important that they should only be taken under medical supervision. In addition, non-drug approaches such as diet and movement as well as surgical interventions such as bariatric operations are also available for weight loss.

Consideration about the weight loss syringe

Dietary supplements and weight loss pills can be potential risks for health. Many of these products promise a quick weight loss, but there is often a lack of scientific evidence of their effectiveness and security. They often contain unregulated or even harmful ingredients that can have negative effects on the body. You can also cause interactions with other drugs and have long -term negative effects on metabolism and organs.

An example of a weight loss product with serious side effects is the weight loss injection. Studies have shown that Wegovy can lead to significant weight loss, but can also cause side effects such as nausea, vomiting, diarrhea and constipation. In addition, cases of gallstones were reported to Wegovy users. Medical authorities therefore warn of the application of these weight loss injection and advise you to search for alternative and safer methods for weight loss.

Overall, dietary supplements, weight loss pills and the weights injections Wegovy should be viewed critically, since the potential risks and side effects can outweigh the possible advantages. It is important to concentrate on a balanced diet, regular physical activity and a healthy lifestyle instead in order to lose weight in the long term.

Dr. Daniel Pehböck, specialist in anesthesia and intensive care medicine, says:

As a doctor, I am looking forward to this medication, as it is intended for patients with high overweight or obesity, for which conventional methods such as diet and movement alone are not sufficiently effective. Alternatives to this drug are limited and often less effective.

The drug can lead to a strong weight loss by either suppressing the appetite, reducing fat recording or stimulating the metabolism. This reduces calorie intake and/or increases calorie burning, which can lead to significant weight loss.

I am confident that this drug will play an important role in the treatment of strong overweight. However, it remains to be seen how long -term consequences for patients will be and what other side effects could still occur. In any case, the use must be considered critically and decided by patient to patient every time.

Weight reduction: These companies are researching weight loss medication

Today there are a large number of companies that intensively research the development of weight loss medication in order to offer effective and safe treatments for weight loss. The leading companies in this area include large pharmaceutical companies such as Pfizer, Novartis and Glaxosmithkline, which invest considerable resources in researching new therapies.

Prominent personalities such as Elon Musk, Kim Kardashian and Boris Johnson have publicly talked about their wish to lose weight and have therefore drawn more attention to the success of such treatments.

The market for weight loss medication is expected to achieve a value of up to $ 100 billion, since the demand for effective methods for weight loss continues to increase worldwide.

Overall, the intensive research and the interest of prominent personalities shows a growing interest and potential in this area in order to develop new and innovative solutions for combating obesity and obesity.

Novo Nordisk

The controversy around Novo Nordisk was mainly created due to the lack of transparency when applying the Semaglutid medication that are used to treat diabetes. Critics claim that the company did not adequately open up how influencers paid to increase the demand for its products. This resulted in consideration of the credibility and impartiality of the information spread by influencers.

The targeted payments to influencers had a significant influence on the market, since they can potentially influence public perception and decisions of consumers. This has led to further criticism of Novo Nordisk because the company obviously tried to increase the demand for its medication without protecting the offered transparency.

The reasons for criticism of Novo Nordisk are diverse, including the lack of disclosure of influencer payments, the possible influence of public opinion and the potential effects on market dynamics.

Eli Lilly

Eli Lilly is a globally acting pharmaceutical company that currently focuses on investment decisions to strengthen his innovation pipeline. A hope is the Mounjaro drug, which hopes for approval for the treatment of certain types of cancer. If the drug is approved, its potential market value is assessed as very promising.

In addition, Eli Lilly plans to build a factory in Germany. This shows the importance of the pharmaceutical location of Germany for the company. The new factory is expected to have a positive effect on the pharmaceutical location and create jobs.

The decision to invest in Germany was influenced by various factors, including the good infrastructure, qualified workers and the proximity to research institutions. Eli Lilly sees Germany as a strategically important location and hopes to keep a strong presence in this market through the investments.

Keywords: Eli Lilly, investment decisions, Mounjaro, approval, pharmaceutical location Germany.


The latest developments in Pfizer in connection with the Danuglipron Obesity Pille show that the company has developed a version of the pill twice a day. In contrast to the ordered pill once a day, which has not proven to be effective enough, the new version should offer better weight loss and thus improved effectiveness in combating obesity. Pfizer has already made significant progress in the development of DANUGLIPRON's two -day version and plans to carry out late clinical studies by the end of the year.

These developments mark an important step forward for Pfizer in the fight against obesity and position the company as an important player on the market for obesity medication. In cooperation with other pharmaceutical companies such as Novo Nordisk, Pfizer drives research and development of medication for weight loss and works to create effective and well -tolerated treatment options for people with obesity.


The experimental obesity medication AMG133 from Amgen has shown promising tendencies in relation to sustainable weight loss. Early clinical studies have shown that the drug can cause significant weight losses in overweight patients. The average weight loss after a twelve -week treatment was around 10% of the body weight.

AMG133 is a promising medication that requires special treatment methods. The patients who take this medication must adhere to a specially developed treatment plan that includes a combination of medication, diet change and regular movement.

Amgen, the company behind AMG133, is a worldwide leading biotechnology company that specializes in the development of innovative medication for the treatment of serious diseases such as cancer, rheumatoid arthritis and osteoporosis.

Overall, the early clinical studies show promising results for the AMG133 obesity medication from Amgen and could make a significant contribution to the treatment of obesity.


The latest developments by Alimtune include the Phase II study on Pemvidutid, a promising drug for weight reduction. The study results showed a significant weight loss of over ten percent among the subjects, which indicates a promising effectiveness of the medication. However, light to moderate side effects such as nausea and headache were also found.

The effectiveness of Pemvidutid in weight reduction is a promising option for patients with obesity and other health risks. Nevertheless, potential risks and side effects when using the drug must be taken into account.

The positive results of the phase II study could have a significant impact on the future of the Alimtune company and have the potential to revolutionize the pharmaceutical market. Should Pemvidutid continue to show promising results in further studies and clinical tests, it could be a real alternative for patients who have to deal with weight problems.

By developing an effective drug for weight reduction, Alimmune could play a leading role on the pharmaceutical market and significantly improve the treatment options for overweight patients.

Viking therapeutics

Viking Therapeutics is a biopharmaceutical company that focuses on the development of new therapies for metabolic diseases and endocrine diseases. One of her most promising medication candidates, VK2735, has recently shown positive results in a phase I study. In this study, the drug was able to reduce the average weight of the subjects by up to six percent.

In view of this promising result, the company is now planning to test higher doses of VK2735 in a longer phase II study. The main focus is on the clinical effectiveness and possible side effects of the drug. The results of this phase II study are expected to create the basis for the further clinical developments of VK2735 and to validate its potential use in weight reduction.

Viking Therapeutics is confident that VK2735 has the potential to make a significant contribution to the treatment of obesity and other metabolic diseases. The progress in the studies underline the company's commitment to develop innovative solutions for pressing health problems.

Boeringer Ingelheim/Zealand Pharma

The cooperation between Boehringer Ingelheim and the Danish Biotech company Zealand Pharma has led to promising results. Her latest phase II study on the weight loss medication showed promising results, but also challenges in taking the agent.

This cooperation continues to strengthen the importance of Rhineland-Palatinate as a pharmaceutical cluster in Germany. The industry continues to strengthen the industry by investing in the pharmaceutical industry in Germany and the planned promotion of pharmaceutical companies. The focus on innovation and cooperation in this region shows that Germany plays an important role in the pharmaceutical industry and will continue to grow. The close cooperation between Boehringer Ingelheim and Zealand Pharma is a good example of how companies and countries work together on the development of new medication and promote the health industry.


OBORK HEALTH is a biopharmaceutical company that focuses on the development of medication for the treatment of various diseases and health states. One of her latest projects is a phase II study for the Pegapamodutide obesity medication that aims at the Hormon GLP-1. The special thing about this drug is that it should have fewer side effects compared to the currently available medication that can often trigger nausea and vomiting.

The study aims to examine the effectiveness and security of Pegapamodutide in the treatment of obesity and is an important step towards a potential new treatment option for this widespread disease. Obesity is a serious health problem that can lead to a variety of complications, including heart disease, diabetes and other serious illnesses.

Obko Health is working hard to develop innovative and effective medication in order to improve the health and well -being of patients. The Pegapamodutid phase-II study is an exciting step in this direction and has the potential to change the lives of many people positively.

Ozempic® for losing weight - what's on the hype?

Ozempic® is a medication that was originally developed to treat type 2 diabetes, but has experienced a real hype due to its side effect of weight loss in recent years. Many people use the drug to lose weight because it can demonstrably lead to a reduction in body weight.

The effect of Ozempic® is based on a hormone that delays the absorption of food and promotes the feeling of satiety. This eats less and therefore lost weight. Many people who have difficulties with conventional methods long for the effect of Ozempic®.

However, there are also risks associated with taking Ozempic®, including nausea, abdominal pain and the risk of pancreatitis. As an alternative, there are other drugs for weight loss as well as proven methods such as a healthy diet and regular movement.

Overall, the hype about Ozempic® is entitled to lose weight, but it is important to take into account the risks and alternatives before you decide to take it.

What is Ozempic®?

Ozempic® is a prescription drug for the treatment of type 2. It contains the active ingredient Semaglutid, which lowers blood sugar levels by increasing insulin production and reducing glucagon production. Ozempic® is administered under the skin once a week as an injection.

The drug can be used alone or in combination with other diabetes medication. Studies have shown that Ozempic® can also help reduce weight, which can be particularly advantageous for people with type 2 diabetes.

Ozempic® should always be used in consultation with a doctor who defines the appropriate dosage and treatment duration. It is important to follow the instructions of the doctor carefully in order to achieve the best possible results and prevent possible side effects.

Overall, Ozempic® can help control the blood sugar level and reduce the risk of diabetes -related complications.

How does Ozempic® work?

Ozempic® is a drug that contains the active ingredient Semaglutide and is used to treat type 2 diabetes and weight loss. The active ingredient has a positive effect on blood sugar levels by increasing the release of insulin from the pancreas and improving sugar in the cells. In addition, SEMAGLUTID also reduces appetite, which leads to a reduction in food intake and thus to a weight loss.

In comparison, Wegovy® is also a medication with the active ingredient Semaglutide, which is used exclusively for weight loss in overweight adults. In contrast to Ozempic®, Wegovy® is administered in a higher dosage and is particularly approved for people with a body mass index (BMI) of over 30 or with a BMI of over 27 in connection with accompanying weight treatment.

Both medication, Ozempic® and Wegovy®, are aimed at people who suffer either from type 2 diabetes or suffer from overweight or obesity and have difficulty reducing their weight. Due to the effect of the active ingredient SEMAGLUTID, both medication can help lower blood sugar levels and reduce body weight.

Why shouldn't Ozempic® be used to lose weight?

Ozempic® is a medication used to treat diabetes. It contains the active ingredient Semaglutid, which is a synthetic intestinal hormone that lowers the blood sugar level. Although some patients who take Ozempic can experience weight loss, it is important to note that the drug is not approved for the purpose of losing weight.

Ozempic's off-label-FREE for weight reduction carries risks because the drug was specially developed for the control of blood sugar levels in diabetes. The dosage and application of Ozempic to lose weight is not checked and monitored, which can lead to undesirable side effects and health risks.

In contrast, WEGOVY® is a newly approved medication that also contains the active ingredient Semaglutide, but was specially developed for weight reduction. The dosage and application of Wegovy® are aimed at the needs of people with overweight and obesity, and in clinical studies it has been demonstrated that it is safe and effective for weight loss.

It is therefore important that Ozempic® is only taken for diabetes treatment in accordance with a doctor's instructions and is not used as a means of reducing weight.

In which doses are there Ozempic®?

Ozempic® is a medication for the treatment of type 2 diabetes, which is available in different doses. The available doses range from 0.25 mg to 1 mg and are administered at weekly intervals. The dosage of Ozempic® may differ for the treatment of obesity and obesity. In this case, the dosage begins at 0.25 mg and increases at weekly intervals to achieve the optimal result. Possible intermediate steps can be taken into account when adjusting the dosage in order to ensure the compatibility and effectiveness of the drug.

The doses of Ozempic® can vary depending on the application. When treating type 2 diabetes, lower doses for patients with restricted kidney function or older patients can be recommended. It is important to adapt the dosage according to the individual needs and the clinical situation. Ozempic® has proven to be effective in the treatment of type 2, obesity and obesity diabetes, and the doses are carefully adjusted to achieve optimal results.

What side effects do Ozempic® occur?

Ozempic® is a prescription drug for the treatment of type 2 diabetes. Possible side effects that can occur when taking Ozempic® are nausea, diarrhea, vomiting, abdominal pain, constipation and loss of appetite. Some patients can also experience reactions at the injection site, such as reddening, swelling or itching.

It is important to pay attention to these side effects when taking OZEMPIC® and consult a doctor if you appear. In many cases, these side effects can be treated by adapting the dosage or by supporting measures such as sufficient fluid intake and a balanced diet.

Another risk related to Ozempic® are fake medication. Patients should make sure that the medication only relates from trustworthy sources to ensure the authenticity and quality of the medication.

It is important that patients with type 2 diabetes are aware of the possible side effects of Ozempic® and obtain medical advice if necessary to ensure that the treatment is safe and effective.

Can you buy Ozempic® without a prescription?

No, Ozempic® is a prescription drug that cannot be acquired without a prescription. It is used for the treatment of type 2 diabetes and is subject to prescription due to its composition of the active ingredient and potential side effects. To get Ozempic®, you first have to go to a doctor and undergo a thorough examination of the state of health. The doctor will then decide whether Ozempic® is the right medication and issue a recipe.

There are also certain restrictions on application for Ozempic®, especially in people with a history of pancreatitis or thyroid diseases. In addition, an off-label muse can occur in some cases where the drug is used to treat obesity, although it is not officially approved for this indication. In this context, the drug Wegovy® is also relevant, which has a similar ingredient composition as Ozempic® and is approved for the treatment of obesity.

Are there alternatives to Ozempic®?

Yes, there are alternative medication for Ozempic®. An alternative drug is Victoza®, the active ingredient of which is liraglutid. The dosage of Victoza® is usually 0.6 mg or 1.2 mg per day. Another alternative drug is Trulicity®, whose active ingredient is dulaglutid. The recommended dosage of Trulicity® is 0.75 mg or 1.5 mg once a week.

Possible side effects of these drugs are nausea, vomiting, diarrhea and abdominal pain. They can be purchased either on a prescription or without a prescription in pharmacies, depending on the local laws and the individual needs of the patient.

It is important to note that fake medication can be in circulation. Warning signs for fake medication include missing batch numbers, unrealistically low prices and missing packaging seals. It is important to obtain medication only from trustworthy sources to ensure security and effectiveness.